Improving HPV vaccination in Latino teens at health centers
Part of Infections clinical trials.
This trial tests a program to help community health centers recommend and boost HPV vaccination rates among Latino adolescents aged 11-12. It aims to support health care providers and staff with education and resources.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Health centers must have less than 60% HPV vaccine start rate for 11-12 year olds
- Health centers must have family medicine or pediatric services
- At least half of the adolescent patients must be Latino
- Health center staff (providers, nurses, administrators) must be willing to receive training and support
- You must be 18 or older to participate as a health center staff member or parent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an implementation program that helps clinics better provide breast and cervical cancer screening and HPV vaccination to Latina women who are behind on recommended care. It may help you catch up on screening or start HPV vaccination and connect you to low-cost services.
This study tests if offering self-sampling for HPV testing makes it easier for people to get screened for cervical cancer. It is designed for patients at partner clinics in Texas who are due for screening.
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
This study tests an educational program to help people in Denver who have not yet started the HPV vaccine (or haven’t finished it) complete the vaccine series. It may help families understand the vaccine and follow through with completing the recommended doses.
This study looks at whether training pharmacy staff in communication and vaccination workflows can improve HPV vaccine recommendations and uptake. If you are a parent or guardian of a child aged 9–17 who has not yet completed the HPV vaccine series, you may be eligible to participate.
This study tests whether real-time reminders and guidance help families stay on track with the HPV vaccine for children who are 11–12 years old. It’s a “feasibility” study, meaning it focuses on whether the approach is practical and acceptable.
Hear when a new Human Papillomavirus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.